Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pavmed Inc (PAVM)

Pavmed Inc (PAVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,886
  • Shares Outstanding, K 9,172
  • Annual Sales, $ 2,450 K
  • Annual Income, $ -64,180 K
  • 60-Month Beta 0.85
  • Price/Sales 7.37
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PAVM with:

Options Overview Details

View History
  • Implied Volatility 78.08% ( -170.04%)
  • Historical Volatility 145.77%
  • IV Percentile 7%
  • IV Rank 2.56%
  • IV High 1,154.29% on 09/06/23
  • IV Low 49.76% on 12/11/23
  • Put/Call Vol Ratio 0.33
  • Today's Volume 8
  • Volume Avg (30-Day) 18
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 289
  • Open Int (30-Day) 139

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.50
  • Growth Rate Est. (year over year) +66,700.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8100 +7.73%
on 04/17/24
2.8400 -31.34%
on 03/27/24
-0.1000 (-4.88%)
since 03/18/24
3-Month
1.6000 +21.88%
on 02/08/24
3.5000 -44.29%
on 02/29/24
-0.9800 (-33.45%)
since 01/18/24
52-Week
1.6000 +21.88%
on 02/08/24
9.3630 -79.17%
on 04/20/23
-6.0000 (-75.47%)
since 04/18/23

Most Recent Stories

More News
PAVmed and Lucid Diagnostics to Participate in Panel Presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference

/PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company operating in the medical device,...

PAVM : 1.9500 (-1.02%)
LUCD : 0.7990 (-0.39%)
Lucid Diagnostics Releases Positive Data from First Prospective Clinical Utility Study of EsoGuard® Esophageal Precancer Detection

/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...

PAVM : 1.9500 (-1.02%)
LUCD : 0.7990 (-0.39%)
PAVmed Provides Business Update and Second Quarter Financial Results

/PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the...

PAVM : 1.9500 (-1.02%)
LUCD : 0.7990 (-0.39%)
Lucid Diagnostics Provides Business Update and Second Quarter Financial Results

/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...

LUCD : 0.7990 (-0.39%)
PAVM : 1.9500 (-1.02%)
PAVmed to Hold a Business Update Conference Call and Webcast on August 16, 2023

/PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the...

PAVM : 1.9500 (-1.02%)
LUCD : 0.7990 (-0.39%)
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 15, 2023

/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and...

PAVM : 1.9500 (-1.02%)
LUCD : 0.7990 (-0.39%)
Lucid Diagnostics to Present at the Canaccord Genuity 43rd Annual Growth Conference

/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid Diagnostics" or "Lucid"), a commercial-stage cancer prevention diagnostics company and a...

PAVM : 1.9500 (-1.02%)
LUCD : 0.7990 (-0.39%)
PAVmed and Lucid Chairman and Chief Executive Officer, Dr. Lishan Aklog, Testifies at U.S. House of Representatives Energy and Commerce Committee, Hearing on Life-Saving Innovations and Medicare Coverage

/PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company, operating in the medical device,...

PAVM : 1.9500 (-1.02%)
LUCD : 0.7990 (-0.39%)
PAVmed Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement

/PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the...

PAVM : 1.9500 (-1.02%)
LUCD : 0.7990 (-0.39%)
PAVmed to Participate in Healthcare Virtual Conference Presented by Maxim Group LLC

/PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company operating in the...

PAVM : 1.9500 (-1.02%)
LUCD : 0.7990 (-0.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation...

See More

Key Turning Points

3rd Resistance Point 2.1285
2nd Resistance Point 2.0693
1st Resistance Point 2.0096
Last Price 1.9500
1st Support Level 1.8907
2nd Support Level 1.8315
3rd Support Level 1.7718

See More

52-Week High 9.3630
Fibonacci 61.8% 6.3975
Fibonacci 50% 5.4815
Fibonacci 38.2% 4.5655
Last Price 1.9500
52-Week Low 1.6000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar